Previous research has consistently demonstrated elevated levels of proinflammatory cytokines, including IL-1β, IL-6, and TNF-α, in patients with DN, and anti-inflammatory therapy is one of the important therapeutic approaches for treating DN [33]. The gene discussed is IL1B; the disease is liver dysplastic nodule.